Literature DB >> 17344271

Prescribing benzodiazepines in general practice: a new view of an old problem.

Anne Rogers1, David Pilgrim, Susie Brennan, Ilyas Sulaiman, Gareth Watson, Carolyn Chew-Graham.   

Abstract

General practitioner (GP) prescribing has been identified as an arena that has broad social and political implications, which stretch beyond individual outcomes for patients. This article revisits aspects of the controversy about prescribing benzodiazepines (or 'minor tranquillizers') through an exploration of contemporary views of GPs. In the 1980s the prescribing of these drugs was considered to be both a clinical and social problem, which brought medical decision making under public scrutiny. The legacy of this controversy for recent GPs remains a relatively under-explored topic. This article describes a qualitative study of GPs practising in the north-west of England about their views of prescribing benzodiazepines. The accounts of the respondents highlight a number of points about: blame allocation, past and present; clinical challenges about risk management; and deserving and undeserving patients. These GP views are then discussed in the wider context of psychotropic drug use. It is concluded that, while there has been a recent consensus that the benzodiazepines have been problematic, when they are placed in a longer historical context, a different picture is apparent because other psychotropic drugs have raised similar problems.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17344271     DOI: 10.1177/1363459307074693

Source DB:  PubMed          Journal:  Health (London)        ISSN: 1363-4593


  13 in total

1.  Variations in anxiolytic and hypnotic prescribing by GPs: a cross-sectional analysis using data from the UK Quality and Outcomes Framework.

Authors:  Zoi Tsimtsiou; Mark Ashworth; Roger Jones
Journal:  Br J Gen Pract       Date:  2009-06       Impact factor: 5.386

Review 2.  Benzodiazepine Use, Misuse, and Harm at the Population Level in Canada: A Comprehensive Narrative Review of Data and Developments Since 1995.

Authors:  Yoko Murphy; Emily Wilson; Elliot M Goldner; Benedikt Fischer
Journal:  Clin Drug Investig       Date:  2016-07       Impact factor: 2.859

3.  Patients' and clinicians' experiences and perceptions of the primary care management of insomnia: qualitative study.

Authors:  Zowie Davy; Jo Middlemass; Aloysius N Siriwardena
Journal:  Health Expect       Date:  2013-08-19       Impact factor: 3.377

4.  Psychiatrist decision-making towards prescribing benzodiazepines: the dilemma with substance abusers.

Authors:  Carla Beth Marienfeld; Ece Tek; Esperanza Diaz; Richard Schottenfeld; Marek Chawarski
Journal:  Psychiatr Q       Date:  2012-12

Review 5.  Withdrawing benzodiazepines in primary care.

Authors:  Malcolm Lader; Andre Tylee; John Donoghue
Journal:  CNS Drugs       Date:  2009       Impact factor: 5.749

Review 6.  General practitioners' experiences and perceptions of benzodiazepine prescribing: systematic review and meta-synthesis.

Authors:  Coral Sirdifield; Sibyl Anthierens; Hanne Creupelandt; Susan Y Chipchase; Thierry Christiaens; Aloysius Niroshan Siriwardena
Journal:  BMC Fam Pract       Date:  2013-12-13       Impact factor: 2.497

7.  Influence of population and general practice characteristics on prescribing of minor tranquilisers in primary care.

Authors:  Andrew C Wagner; Mark Hann; Daren M Ashcroft
Journal:  Pharm Pract (Granada)       Date:  2010-03-15

8.  Medication management and practices in prison for people with mental health problems: a qualitative study.

Authors:  Robert A Bowen; Anne Rogers; Jennifer Shaw
Journal:  Int J Ment Health Syst       Date:  2009-10-20

Review 9.  Prescriber barriers and enablers to minimising potentially inappropriate medications in adults: a systematic review and thematic synthesis.

Authors:  Kristen Anderson; Danielle Stowasser; Christopher Freeman; Ian Scott
Journal:  BMJ Open       Date:  2014-12-08       Impact factor: 2.692

10.  Prescriptions and proscriptions: moralising sleep medicines.

Authors:  Jonathan Gabe; Catherine M Coveney; Simon J Williams
Journal:  Sociol Health Illn       Date:  2015-11-20
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.